< PreviousABSTRACTS10 Abstracts Nr & Co-authors Presentation Nr TitlePresenterDateTime Inter- vention LocationSession Code Session TypeSessionSession Time Category 38P0135 The effect of ceftazidime/avibactam/aztreonam on clinical multidrug-resistant P. aeruginosa isolates from Germany Esther Wohl- farth 15-04-202312:00 Poster Area PS019 Poster Session 3b. Resistance surveillance and epidemiology: Gram-negatives 12:00 03. Bacterial suscepti bility & resistance Esther Wohlfarth (1), Michael Kresken (1), Jessica Eisfeld (2), Niels Pfennigwerth (2), Sören Gatermann (2) - (1) Antiinfectives Intelligence Gmbh, Germany, (2) Ruhr-Universität Bochum, Germany 39P3254 Mycobacterium bovis infection in a child: a case report Annamaria Masucci 18-04-202312:00 Poster Area PS095 Poster Session 13b. Bacterial infections12:00 13. Case reports and case series (n<10) Antonella Pocognoli (1), Guido Zeni (1), Annamaria Masucci (1), Domenico Trotta (1), Lucia Teodori (1), Francesca Orecchioni (1), Gianluca Morroni (2), Federica Zallocco (3), Ines Carloni (3), Marco Moretti (1) - (1) Regional Reference Mycobacteria Unit – Sod Laboratory Medicine Azienda Ospedaliero Universitaria Delle Marche, Italy, (2) Microbiology Unit, Department Of Biomedical Sciences And Public Health, Polytechnic University Of Marche, Ancona, Italy, (3) Infection Disease Unit, Department Of Pediatrics, Salesi Paediat ric Hospital - Ancona (Italy), Italy 43P2975 Safety of empirical antibiotic therapy discontinuing for fever of unknown origin during prolonged and profound neutropaenia in children Clément Le- maigre 17-04-202312:00 Poster Area PS070 Poster Session 10b. Infections in immunocompro- mised hosts (incl. epidemiology, clinical features and diagnosis, treatment, excl. fungal infections) 12:00 10. Immunology, Immune compromise & vaccinology Clément Lemaigre, Hélène Deutsch, France Roblot, José Miguel Torregrosa Diaz, Blandine Rammaert - (1) Poitiers University Hospital, France 44P2090 A polymorphism in IL1B is associated with immune reconstitution inflammatory syndrome due to chronic disseminated candidiasis Pierre Yves Bochud 16-04-202312:00 Poster Area PS046 Poster Session 6e. Basic mycology (incl. in vitro and in vivo studies, pathogenesis) 12:00 06. Fungal infection & disease Blandine Rammaert (1), Pierre Yves Bochud (2), Anne Sophie Brunel (2), Agnieszka Wojtowicz (2), Sophie Candon (3), Maria Pilar Gallego Hernanz (1), Olivier Lortholary (4) - (1) Poitiers University Hospital, France, (2) University Hospital And University Of Lausanne, Switzerland, (3) Rouen University Hospital, France, (4) Université De Paris Cité, Aphp, Hôpital Necker-Enfants Malades, France 47P0672 Predictive factors for failure of antibiotic lock therapy to treat long-term central venous cathe- ter-related infections in adult cancer patients Axel Thomas15-04-202312:00 Poster Area PS055 Poster Session 8a. Intravascular catheter-related infections 12:00 08. Healthcare-as sociated infections, infection prevention & control Axel Thomas, Maxime Pichon, Camille Evrard, Niels Moya, France Roblot, José Miguel Torregrosa Diaz, Blandine Rammaert - (1) Poitiers University Hospital, France 49P0013 Correlation of genotypes with phenotyping results of 515 Staphylococcus aureus isolates from inva- sive infections in one university-affiliated medical centre (2011-2018) Wei-Yao Wang15-04-202312:00 Poster Area PS018 Poster Session 3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives 12:00 03. Bacterial suscepti bility & resistance Wei-Yao Wang, Shih-Ming Tsao - (1) Chung Shan Medical University Hospital, Taiwan, Republic Of China 52O0619 Occurrence of cefiderocol (CFDC) heteroresistance incarbapenem-resistantAcinetobacter bauman- nii(CRAB) cellsafter exposure to human fluids Maria Soledad Ramirez 16-04-202314:57Hall LOS129 1-hour Oral Session Novel resistance mechanisms14:45 03. Bacterial suscepti bility & resistance Jenny Escalante (1), Brent Nishimura (1), Vyanka Mezcord (1), German Traglia (2), Quentin Valle (3), Marisel Tuttobene (4), Tomas Subils (5), Fernando Pasteran (6), Marcelo Tolmasky (1), Robert A Bonomo (7), Gauri Rao (3), Maria Soledad Ramirez (1) - (1) California State University Fullerton, United States, (2) Universidad De La Republica, Uruguay, (3) University Of North Carolina, United States, (4) Ibr-Conicet, Argentina, (5) Iprobyq, Conicet-Unr), Argentina, (6) Malbran, Argentina, (7) Louis Stokes Cleveland Department Of Veterans Affairs Medical Center, United States 54P2711 Kinetics of adaptive immune responses after administering mRNA-based COVID-19 vaccination in individuals with and without prior SARS-CoV-2 infections Sunjoo Kim17-04-202312:00 Poster Area PS088 Poster Session 12g. Vaccine development, trials, efficacy, policy 12:0012. COVID-19 Sunjoo Kim (1), Kristin Widyasari (1), Won-Hee Choi (2), Hye-Ryun Yang (3) - (1) Department Of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Korea, Republic Of, (2) Department Of Nursing Science, Kyungsung University, Korea, Republic Of, (3) Gyeongnam Center For Infectious Disease Control And Prevention, Korea, Republic Of 56E1156 Delayed tetracycline initiation increases mortality risk in patients with Japanese spotted fever: a retrospective analysis using a national inpatient database Kutsuna Satoshi18-04-20239:06Arena 1EF235 1-hour ePoster Flash Session Emerging and re-emerging bacteri- al infections 8:30 02. Bacterial infection & disease Kutsuna Satoshi (1), Ohbe Hiroyuki (2), Matsui Hiroki (2), Yasunaga Hideo (2) - (1) Department Of Infection Control, Graduate School Of Medicine Faculty Of Medicine, Osaka University, Japan, (2) Department Of Clinical Epidemiology And Health Economics, School Of Public Health, The University Of Tokyo, Japan 58P3260 Indigenous melioidosis presenting as septic arth- ritis in a Filipino patient with severe COVID-19: a case report Ma. Klaudyn Cletz Genese 18-04-202312:00 Poster Area PS095 Poster Session 13b. Bacterial infections12:00 13. Case reports and case series (n<10) Ma. Klaudyn Cletz Genese, Bernard Demot, Samantha Bartolo, Charls Tan Ariz, Joyce Cortez - (1) Baguio General Hospital And Medical Center, Philippines 61P0004 Comparison of antibacterial activity between electrospun polyacrylonitrite (PAN), copper nano- particle (CuNP), and silver nanoparticle (AgNP) nanofibers against different Staphylococcus aureus strains Wei-Yao Wang15-04-202312:00 Poster Area PS018 Poster Session 3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives 12:00 03. Bacterial suscepti bility & resistance Wei-Yao Wang (1), William B Wang (2), Shih-Ming Tsao (1) - (1) Chung Shan Medical University Hospital, Taiwan, Republic Of China, (2) Taipei American School, Taiwan, Republic Of China 64P2631 Population pharmacokinetics of sotrovimab: a monoclonal antibody for treatment of COVID-19 Jennifer Sager17-04-202312:00 Poster Area PS086 Poster Session 12e. Drug development and treatment modalities (incl. in vitro, animal, clinical trials, resistance) 12:0012. COVID-19 Jennifer Sager (1), Asma El-Zailik (1), Julie Passarell (2), Stefan Roepcke (2), Xiaobin Li (3), Melissa Aldinger (1), Ahmed Nader (3), Andrew Skingsley (4), Erik Mogalian (1), Chad Garner (1), Amanda Peppercorn (3), Maribel Reyes (1) - (1) Vir Biotechnology, United States, (2) Cognigen Division, Simulations Plus, Inc, United States, (3) Gsk, United States, (4) Gsk, United Kingdom 65P2551 SARS-CoV-2 infection timing as a predictor of adverse neonatal outcome Eduardo Rey- na-Villasmil 17-04-202312:00 Poster Area PS084 Poster Session 12c. Clinical features, case ma- nagement, complications, outco- me (incl. long-term) 12:0012. COVID-19 Holly Michaels (1), Bella Rolland (2), Danica James (3), Nikki Elliot (4), Alison Tyler (5), Jorly Mejia-Montilla (6), Eduardo Reyna-Villasmil (6) - (1) Department Of Obstetrics. Lexington Medical Center., United States, (2) Center For Women’S Reproductive Health. Lexington Medical Center, United States, (3) Department Of Obstetrics And Gynecology, United States, (4) Department Of Public Health And Primary Care, United States, (5) Department Of Public Health And Primary Care. Lexington Medical Center, United States, (6) Service Of Applied Science. Healthnomics, Spain 67P2435 Asymptomatic/mild SARS-CoV-2 disease during pregnancy and fetal growth restriction Eduardo Rey- na-Villasmil 17-04-202312:00 Poster Area PS083 Poster Session 12b. Epidemiology - local, regio- nal, national, global 12:0012. COVID-19 Holly Michales (1), Bella Rolland (2), Danica James (3), Nikki Elliot (4), Alison Tyler (5), Jorly Mejia-Montilla (6), Eduardo Reyna-Villasmil (6) - (1) Department Of Obstetrics. Lexington Medical Center., United States, (2) Center For Women’S Reproductive Health. Lexington Medical Center., United States, (3) Department Of Obstetrics And Gynecology. Lexington Medical Center., United States, (4) Department Of Public Health And Primary Care. Lexington Medical Center, United States, (5) Department Of Public Health And Primary Care. Lexington Medical Center., United States, (6) Service Of Applied Science. Healthnomics, Spain 68P2518 Placental pathological alterations in pregnant women with SARS-CoV-2 infection Eduardo Rey- na-Villasmil 17-04-202312:00 Poster Area PS084 Poster Session 12c. Clinical features, case ma- nagement, complications, outco- me (incl. long-term) 12:0012. COVID-19 Holly Michaels (1), Bella Rolland (2), Danica James (3), Nikki Elliot (4), Alison Tyler (4), Jorly Mejia-Montilla (5), Eduardo Reyna-Villasmil (5) - (1) Department Of Obstetrics. Lexington Medical Center., United States, (2) Center For Women’S Reproductive Health. Lexington Medical Center., United States, (3) Department Of Obstetrics And Gynecology. Lexington Medical Center., United States, (4) Department Of Public Health And Primary Care. Lexington Medical Center., United States, (5) Service Of Applied Science. Healthnomics, Spain 70P2507 SARS-CoV-2 infection and placental injury patterns according to the severity of disease and gestati- onal age Jorly Me- jia-Montilla 17-04-202312:00 Poster Area PS084 Poster Session 12c. Clinical features, case ma- nagement, complications, outco- me (incl. long-term) 12:0012. COVID-19 Holly Michaels (1), Bella Rolland (2), Danica James (3), Nikki Elliot (4), Alison Tyler (4), Jorly Mejia-Montilla (5), Eduardo Reyna-Villasmil (5) - (1) Department Of Obstetrics. Lexington Medical Center., United States, (2) Center For Women’S Reproductive Health. Lexington Medical Center, United States, (3) Department Of Obstetrics And Gynecology. Lexington Medical Center., United States, (4) Department Of Public Health And Primary Care. Lexington Medical Center, United States, (5) Service Of Applied Science. Healthnomics., Spain 71P1949 The mortality rate of non-HIV infected patients with cryptococcosis: the real-world data from one referral centre in northeastern Thailand Monprach Harnphadung- kit 16-04-202312:00 Poster Area PS042 Poster Session 6a. Fungal disease epidemiology12:00 06. Fungal infection & disease Monprach Harnphadungkit (1), Parinya Chamnan (2), Suwatthiya Kitsaran (3) - (1) Division Of Infectious Disease, Department Of Medicine, Faculty Of Medicine, Chulalongkorn University, Thailand, (2) Cardio-Metabolic Research Group, Sunpasitthiprasong Hospital, Thailand, (3) Division Of Infectious Diseases, Department Of Medicine, Sunpasitthiprasong Hospital, ThailandFINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 2023 11 CategorySub-categoryLink AbstractsLink EposterLink Oral Session 03. Bacterial suscepti- bility & resistance 3b. Resistance surveillance & epidemio- logy: Gram-negatives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11188&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0135 13. Case reports and ase series (n<10) 13b. Bacterial infections https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11189&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P3254 atory Medicine Azienda Ospedaliero Universitaria Delle Marche, Italy, (2) Microbiology Unit, Department Of Biomedical Sciences And Public Health, Polytechnic University Of Marche, Ancona, Italy, (3) Infection Disease Unit, Department Of Pediatrics, Salesi Paediat- 10. Immunology, mmune compromise & vaccinology 10b. Infections in immunocompromi- sed hosts (incl. epidemiology, clinical features and diagnosis, treatment, excl. fungal infections) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11193&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2975 06. Fungal infection & disease 6e. Basic mycology (incl. in vitro and in vivo studies, pathogenesis) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11194&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2090 Switzerland, (3) Rouen University Hospital, France, (4) Université De Paris Cité, Aphp, Hôpital Necker-Enfants Malades, France 08. Healthcare-as- ociated infections, nfection prevention & ontrol 8a. Intravascular catheter-related infections https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11197&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0672 03. Bacterial suscepti - bility & resistance 3a. Resistance surveillance & epide- miology: MRSA, VRE & other Gram-po- sitives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11199&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0013 03. Bacterial suscepti- bility & resistance 3d. Resistance mechanisms incl. in vitro and in vivo studies, mobile elements (excl. TB) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11202&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-16&openSession=OS129 a State University Fullerton, United States, (2) Universidad De La Republica, Uruguay, (3) University Of North Carolina, United States, (4) Ibr-Conicet, Argentina, (5) Iprobyq, Conicet-Unr), Argentina, (6) Malbran, Argentina, (7) Louis Stokes Cleveland Department Of 12. COVID-19 12g. Vaccine development, trials, efficacy, policy https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11204&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2711 c Of, (3) Gyeongnam Center For Infectious Disease Control And Prevention, Korea, Republic Of 02. Bacterial infection & disease 2g. Zoonotic bacterial infections (incl. foodborne, waterborne and vector-bor- ne pathogens, veterinary microbiology and One Health aspects, excl. AMR) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11206&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=E1156https://online.eccmid.org/programme-live-1?coday=2023-04-18&openSession=EF235 Of Public Health, The University Of Tokyo, Japan 13. Case reports and ase series (n<10) 13b. Bacterial infections https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11208&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P3260 03. Bacterial suscepti- bility & resistance 3a. Resistance surveillance & epide- miology: MRSA, VRE & other Gram-po- sitives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11211&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0004 12. COVID-19 12e. Drug development and treatment modalities (incl. in vitro, animal, clinical trials, resistance) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11214&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2631 tes, (2) Cognigen Division, Simulations Plus, Inc, United States, (3) Gsk, United States, (4) Gsk, United Kingdom 12. COVID-19 12c. Clinical features, case manage- ment, complications, outcome (incl. long-term) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11215&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2551 gton Medical Center, United States, (3) Department Of Obstetrics And Gynecology, United States, (4) Department Of Public Health And Primary Care, United States, (5) Department Of Public Health And Primary Care. Lexington Medical Center, United States, (6) 12. COVID-19 12b. Epidemiology - local, regional, national, global https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11217&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2435 gton Medical Center., United States, (3) Department Of Obstetrics And Gynecology. Lexington Medical Center., United States, (4) Department Of Public Health And Primary Care. Lexington Medical Center, United States, (5) Department Of Public Health And Primary 12. COVID-19 12c. Clinical features, case manage- ment, complications, outcome (incl. long-term) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11218&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2518 gton Medical Center., United States, (3) Department Of Obstetrics And Gynecology. Lexington Medical Center., United States, (4) Department Of Public Health And Primary Care. Lexington Medical Center., United States, (5) Service Of Applied Science. Healthnomics, 12. COVID-19 12c. Clinical features, case manage- ment, complications, outcome (incl. long-term) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11220&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2507 gton Medical Center, United States, (3) Department Of Obstetrics And Gynecology. Lexington Medical Center., United States, (4) Department Of Public Health And Primary Care. Lexington Medical Center, United States, (5) Service Of Applied Science. Healthnomics., 06. Fungal infection & disease 6a. Fungal disease epidemiology https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11221&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1949 Thailand, (3) Division Of Infectious Diseases, Department Of Medicine, Sunpasitthiprasong Hospital, ThailandABSTRACTS12 Abstracts Nr & Co-authors Presentation Nr TitlePresenterDateTime Inter- vention LocationSession Code Session TypeSessionSession Time Category 73P2480 Vertical transmission and humoral immune res- ponse to SARS-CoV-2 infection Jorly Me- jia-Montilla 17-04-202312:00 Poster Area PS084 Poster Session 12c. Clinical features, case ma- nagement, complications, outco- me (incl. long-term) 12:0012. COVID-19 Alison Tyler (1), Nikki Elliot (2), Danica James (3), Bella Rolland (4), Holly Michaels (5), Jorly Mejia-Montilla (6), Eduardo Reyna-Villasmil (6) - (1) Department Of Public Health And Primary Care. Lexington Medical Center., United States, (2) Department Of Public Health And Primary Care. Lexington Medical Center, United States, (3) Department Of Obstetrics And Gynecology. Lexington Medical Center, United States, (4) Center For Women’S Reproductive Health. Lexington Medical Center., United States, (5) Department Of Obste trics. Lexington Medical Center., United States, (6) Service Of Applied Science. Healthnomics, Spain 76P2482 Inflammatory marker values and severity of SARS- CoV-2 infection during pregnancy Jorly Me- jia-Montilla 17-04-202312:00 Poster Area PS084 Poster Session 12c. Clinical features, case ma- nagement, complications, outco- me (incl. long-term) 12:0012. COVID-19 Alison Tyler (1), Nikki Elliot (1), Danica James (2), Bella Rolland (3), Holly Michaels (4), Jorly Mejia-Montilla (5), Eduardo Reyna-Villasmil (5) - (1) Department Of Public Health And Primary Care. Lexington Medical Center., United States, (2) Department Of Obstetrics And Gynecology. Lexington Medical Center, United States, (3) Center For Women’S Reproductive Health. Lexington Medical Center., United States, (4) Department Of Obstetrics. Lexington Medical Center., United States, (5) Service Of Applied Science. Healthnomics, Spain 78O0930 DisseminatedMycobacterium kansasiiinfec- tionwithhemophagocytic lymphohistiocyto- sis(HLH) : acase report Warinthip Mahapasut- hanon 17-04-202314:14Hall MOS193 1-hour Case Session NTMs keep surprising us!13:30 13. Case reports and case series (n<10) Warinthip Mahapasuthanon, Kamonwan Jutivorakool - (1) Division Of Infectious Diseases, Department Of Medicine, Faculty Of Medicine, Chulalongkorn University, Thailand 80O0618 Novel ramRpoint mutations led to eravacycline re- sistance and increasedvirulence in clinical isolates of Klebsiella pneumoniae Wei Yu16-04-202314:45Hall LOS129 1-hour Oral Session Novel resistance mechanisms14:45 03. Bacterial suscepti bility & resistance Wei Yu (1, 2), Peiyao Jia (2) - (1) Graduate School, Peking Union Medical College, Chinase Academy Of Medical Sciences, China, (2) Department Of Clinical Laboratory, State Key Laboratory Of Complex Severe And Rare Diseases, Peking Union Medical College Hospital, Chinase Academy Of Medical Sciences And Peking Union Medical College, China 82P3253Brucellosis associated with acute cholecystitisYousra Kherabi18-04-202312:00 Poster Area PS095 Poster Session 13b. Bacterial infections12:00 13. Case reports and case series (n<10) Yasemin Cakir (1), Yousra Kherabi (2) - (1) Agri Dogubaayzit State Hospital,Infectious Diseases And Clinical Microbiology Clinic, Turkey, (2) Department Of Infectious Diseases, Bichat-Claude Bernard Hospital, France 83P2869 Performance evaluation of a high throughput CMV PCR assay for the detection and quantification of cytomegalovirus DNA in urine, saliva and vaginal secretions Ngee Keong Tan 17-04-202312:00 Poster Area PS004 Poster Session 1d. Herpesviruses (incl. diagno- stics & epidemiology, antiviral drugs, treatment & susceptibility/ resistance, excl. clinical studies in immunocompromised hosts) 12:00 01. Viral infection & di sease (non COVID-19) Ngee Keong Tan (1, 2), David Carrington (3), Cassie Pope (3, 4) - (1) South West London Pathology, St George‘S University Hospitals Nhs Foundation Trust, United Kingdom, (2) Faculty Of Biology, Medicine And Health, University Of Manchester, United Kingdom, (3) Infection Care Group, St George‘S University Hospitals Nhs Foundation Trust, United Kingdom, (4) Institute For Infection And Immunity, St George’S University Of London, United Kingdom 85P1475 Challanges in diagnosing neuroborreliosis: a comparison of diagnostic strategies in the light of local seroprevalence András Zóka16-04-202312:00 Poster Area PS016 Poster Session 2g. Zoonotic bacterial infections (incl. foodborne, waterborne and vector-borne pathogens, veteri- nary microbiology and One Health aspects, excl. AMR) 12:00 02. Bacterial infection & disease András Zóka, András Baráth, Jennifer Bacsó, Márton Gönczi, Gabriella Bekő - (1) South-Pest Central Hospital, Hungary 87P3456 Symptomatic pulmonary histoplasmosis after mild COVID-19 infection Michael Gabri- lovich 18-04-202312:00 Poster Area PS098 Poster Session 13e. Other unusual clinical situ- ations 12:00 13. Case reports and case series (n<10) Michael Gabrilovich (1), George Smulian (2) - (1) Kettering Health Hamilton Hospital, United States, (2) University Of Cincinnati, United States 90P2544 Placental transfer of specific maternal antibodies against SARS-CoV-2 to newborns Eduardo Rey- na-Villasmil 17-04-202312:00 Poster Area PS084 Poster Session 12c. Clinical features, case ma- nagement, complications, outco- me (incl. long-term) 12:0012. COVID-19 Alison Tyler (1), Nikki Elliot (1), Danica James (2), Bella Rolland (3), Holly Michaels (4), Jorly Mejia-Montilla (5), Eduardo Reyna-Villasmil (5) - (1) Department Of Public Health And Primary Care. Lexington Medical Center., United States, (2) Department Of Obstetrics And Gynecology. Lexington Medical Center., United States, (3) Center For Women’S Reproductive Health. Lexington Medical Center, United States, (4) Department Of Obstetrics. Lexington Medical Center., United States, (5) Service Of Applied Science. Healthnomics, Spain 91P3454 Brain abscess caused by group A streptococcus in HIV-infected patient: a case report and literature review Sireethorn Nimitvilai 18-04-202312:00 Poster Area PS098 Poster Session 13e. Other unusual clinical situ- ations 12:00 13. Case reports and case series (n<10) Sireethorn Nimitvilai, Wichuda Thammaprasert - (1) Nakhonpathom Hospital, Thailand 92P1906 Laboratory capacities to diagnose and treat inva- sive fungal infections in Nordic countries: results from an NSMM and ECMM survey Jon Salman- ton-García 16-04-202312:00 Poster Area PS042 Poster Session 6a. Fungal disease epidemiology12:00 06. Fungal infection & disease Jon Salmanton-García (1), Martin Hoenigl (2), Ramona Santini (3), Volkan Özenci (3), Oliver Cornely (1) - (1) University Of Cologne, Faculty Of Medicine And University Hospital Cologne, Cecad, Germany, (2) Medical University Graz, Austria, (3) Karolinska University Hospital, Sweden 94P1091 Assessment of the incidence of active tuberculosis disease among people living with HIV/AIDS who took isoniazid preventive therapy Mintamir Admassu 16-04-202312:00 Poster Area PS010 Poster Session 2a. Tuberculosis and other mycob- acterial infections (incl. epidemio- logy, clinical, diagnostics, antimy- cobacterial drugs, susceptibility testing, treatment & prevention) 12:00 02. Bacterial infection & disease Mintamir Admassu, Tsegab Weldeamanuel, Sirgut Degu - (1) Aahb, Éthiopie 95P2565 SARS-CoV-2 infection during pregnancy and new- born birthweight Eduardo Rey- na-Villasmil 17-04-202312:00 Poster Area PS084 Poster Session 12c. Clinical features, case ma- nagement, complications, outco- me (incl. long-term) 12:0012. COVID-19 Holly Michaels (1), Bella Rolland (2), Danica James (3), Nikki Elliot (4), Alison Tyler (4), Jorly Mejia-Montilla (5), Eduardo Reyna-Villasmil (5) - (1) Department Of Obstetrics. Lexington Medical Center, United States, (2) Center For Women’S Reproductive Health. Lexington Medical Center., United States, (3) Department Of Obstetrics And Gynecology. Lexington Medical Center., United States, (4) Department Of Public Health And Primary Care. Lexington Medical Center., United States, (5) Service Of Applied Science. Healthnomics, Spain 97P1567 Use and quality of in-house microbiological ana- lyses in veterinary companion animalpractices: a survey-based investigation Peter Damborg16-04-202312:00 Poster Area PS026 Poster Session 4a. Diagnostic bacteriology (incl. culture based, traditional and general microbiology, serology) 12:00 04. Diagnostic micro biology Peter Damborg, Marc Marcel Kondrup, Julie Kirkemann Riisby - (1) University Of Copenhagen, Denmark 98P1443 Extended-spectrum beta-lactamases (ESBL) pro- ducing among multidrug-resistant Escherichia coli and Klebsiella pneumoniae in a tertiary care centre, southern Thailand: a public health concern Phanvasri Saengsuwan 16-04-202312:00 Poster Area PS015 Poster Session 2f. Community acquired nervous system and other multi-system bacterial infections(incl. epide- miology, clinical, imaging, treat- ment & prevention) 12:00 02. Bacterial infection & disease Chonticha Romyasamit (1), Phoomjai Sornsenee (2), Soontara Kawila (3), Phanvasri Saengsuwan (4) - (1) Department Of Medical Technology, School Of Allied Health Sciences, Walailak University, Thailand, (2) Department Of Family And Preventive Medicine, Faculty Of Medicine, Prince Of Songkla University, Thailand, (3) Clinical Microbiology, Department Of Pathology, Faculty Of Medicine, Prince Of Songkla University, Thailand, (4) Department Of Biomedical Sciences And Biomedical Engineering, Faculty Of Medicine, Prince Of Songkla University, Thailand 99O0560 Adeno-associated virus 2 (AAV2) infection in children with non-A-E hepatitis in Ireland Julie-Anne Houlihan 16-04-202313:30Hall JOS116 1-hour Oral Session Viral hepatitis epidemiology to prevention 13:30 01. Viral infection & di sease (non COVID-19) Christine Campbell (1), Michael Carr (1), Julie-Anne Houlihan (1), Emer Liddy (2), Suzanne Cotter (2), Jonathan Dean (1), Cillian Degascun (1) - (1) National Virus Reference Lab, Ireland, (2) Health Protection Surveillance Centre, Ireland 100P3445 Herpes simplex virus 2, an unusual cause of is- chaemic stroke in HIV-infected patient: case report and review of literature Sireethorn Nimitvilai 18-04-202312:00 Poster Area PS098 Poster Session 13e. Other unusual clinical situ- ations 12:00 13. Case reports and case series (n<10) Sireethorn Nimitvilai, Wichuda Thammaprasert - (1) Nakhonpathom Hospital, ThailandFINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 2023 13 CategorySub-categoryLink AbstractsLink EposterLink Oral Session 12. COVID-19 12c. Clinical features, case manage- ment, complications, outcome (incl. long-term) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11223&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2480 th And Primary Care. Lexington Medical Center, United States, (3) Department Of Obstetrics And Gynecology. Lexington Medical Center, United States, (4) Center For Women’S Reproductive Health. Lexington Medical Center., United States, (5) Department Of Obste- 12. COVID-19 12c. Clinical features, case manage- ment, complications, outcome (incl. long-term) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11226&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2482 And Gynecology. Lexington Medical Center, United States, (3) Center For Women’S Reproductive Health. Lexington Medical Center., United States, (4) Department Of Obstetrics. Lexington Medical Center., United States, (5) Service Of Applied Science. Healthnomics, 13. Case reports and ase series (n<10) 13b. Bacterial infections https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11228&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-17&openSession=OS193 03. Bacterial suscepti- bility & resistance 3d. Resistance mechanisms incl. in vitro and in vivo studies, mobile elements (excl. TB) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11230&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-16&openSession=OS129 al, Chinase Academy Of Medical Sciences And Peking Union Medical College, China 13. Case reports and ase series (n<10) 13b. Bacterial infections https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11232&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P3253 01. Viral infection & di- ease (non COVID-19) 1d. Herpesviruses (incl. diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11233&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2869 nfection Care Group, St George‘S University Hospitals Nhs Foundation Trust, United Kingdom, (4) Institute For Infection And Immunity, St George’S University Of London, United Kingdom 02. Bacterial infection & disease 2g. Zoonotic bacterial infections (incl. foodborne, waterborne and vector-bor- ne pathogens, veterinary microbiology and One Health aspects, excl. AMR) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11235&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1475 13. Case reports and ase series (n<10) 13e. Other unusual clinical situations https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11237&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P3456 12. COVID-19 12c. Clinical features, case manage- ment, complications, outcome (incl. long-term) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11240&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2544 And Gynecology. Lexington Medical Center., United States, (3) Center For Women’S Reproductive Health. Lexington Medical Center, United States, (4) Department Of Obstetrics. Lexington Medical Center., United States, (5) Service Of Applied Science. Healthnomics, 13. Case reports and ase series (n<10) 13e. Other unusual clinical situations https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11241&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P3454 06. Fungal infection & disease 6a. Fungal disease epidemiology https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11242&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1906 Hospital, Sweden 02. Bacterial infection & disease 2a. Tuberculosis and other mycobac- terial infections (incl. epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11244&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1091 12. COVID-19 12c. Clinical features, case manage- ment, complications, outcome (incl. long-term) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11245&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2565 gton Medical Center., United States, (3) Department Of Obstetrics And Gynecology. Lexington Medical Center., United States, (4) Department Of Public Health And Primary Care. Lexington Medical Center., United States, (5) Service Of Applied Science. Healthnomics, 04. Diagnostic micro- biology 4a. Diagnostic bacteriology (incl. culture based, traditional and general microbio- logy, serology) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11247&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1567 02. Bacterial infection & disease 2f. Community acquired nervous sys- tem and other multi-system bacterial infections (incl. epidemiology, clinical, imaging, treatment & prevention) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11248&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1443 y Of Medicine, Prince Of Songkla University, Thailand, (3) Clinical Microbiology, Department Of Pathology, Faculty Of Medicine, Prince Of Songkla University, Thailand, (4) Department Of Biomedical Sciences And Biomedical Engineering, Faculty Of Medicine, Prince 01. Viral infection & di- ease (non COVID-19) 1b. Viral hepatitis (incl. diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11249&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-16&openSession=OS116 13. Case reports and ase series (n<10) 13e. Other unusual clinical situations https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11250&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P3445ABSTRACTS14 Abstracts Nr & Co-authors Presentation Nr TitlePresenterDateTime Inter- vention LocationSession Code Session TypeSessionSession Time Category 102P3078 Giardia assemblages and diarrhoea in children below five years in Siaya county, Kenya Esther Omuseni17-04-202312:00 Poster Area PS047 Poster Session 7a. Parasitic disease epidemiology12:00 07. Parasitic diseases & global health Esther Omuseni (1), John Ochieng (1), Collins Ouma (2) - (1) Kenya Medical Research Institute, Kisumu, Kenya, Kenya, (2) Maseno Umiversity, Kenya 105P3434 Occupational Plasmodium falciparum malaria following accidental blood exposure Helmi Ernandes18-04-202312:00 Poster Area PS097 Poster Session 13d. Parasitic infections12:00 13. Case reports and case series (n<10) Helmi Ernandes (1), Olfa Smaoui (2) - (1) Mohamed Kassab Institute Of Orthopedics, Tunisia, (2) La Rabta Hospital, Tunisia 110P0445 Role of efflux pumps in physiology and survival of Acinetobacter baumannii Inga Leus15-04-202312:00 Poster Area PS021 Poster Session 3d. Resistance mechanisms incl. in vitro and in vivo studies, mobile elements (excl. TB) 12:00 03. Bacterial suscepti bility & resistance Inga Leus, Drake Willliams, Sean Roberts, Helen Zgurskaya - (1) University Of Oklahoma, United States 111P2428 Epidemiological investigation of paediatric respira- tory tract infections by FilmArray respiratory panel during COVID-19 pandemic in Japan Akira Ukimura17-04-202312:00 Poster Area PS083 Poster Session 12b. Epidemiology - local, regio- nal, national, global 12:00 12. COVID-19 Akira Ukimura (1), Takahisa Ohira (1), Taku Ogawa (1), Takashi Nakano (2) - (1) Infection Control Center, Osaka Medical And Pharmaceutical University Hospital, Japan, (2) Department Of Microbiology And Infection Control, Faculty Of Medicine, Osaka Medical And Pharmaceutical University, Japan 113E0079 A magnetic resonance imaging (MRI) -based objec- tive scoring system to differentiate tubercular and pyogenic spondylitis in low-resource settings Nitin Gupta15-04-20238:42Arena 1EF015 1-hour ePoster Flash Session Bacteria in the soft tissue and bone 8:30 02. Bacterial infection & disease Nitin Gupta, Kavitha Saravu - (1) Kasturba Medical College, Manipal Academy Of Higher Education, India 114P2567 Incidence and risk factor of CMV viremia in severe COVID-19 Jae Hyoung Im17-04-202312:00 Poster Area PS084 Poster Session 12c. Clinical features, case ma- nagement, complications, outco- me (incl. long-term) 12:0012. COVID-19 Jae Hyoung Im (1), Jung Soo Kim (1), Se Joo Lee (1), Ji Hyeon Baek (1), Dong Yoon Kang (2), Jin-Soo Lee (1) - (1) Inha University, Korea, Republic Of, (2) Ulsan University Hospital, Korea, Republic Of 120P2629 Bemnifosbuvir (AT-527) treatment of non-hospita- lized individuals with mild to moderate COVID-19: results from a truncated phase 3, randomized, double-blind, placebo-controlled trial (MOR- NINGSKY) Maria Arantxa Horga 17-04-202312:00 Poster Area PS086 Poster Session 12e. Drug development and treatment modalities (incl. in vitro, animal, clinical trials, resistance) 12:0012. COVID-19 Maria Arantxa Horga (1), Rebecca Saenz (2), Keith Pietropaolo (1), William Stubbings (3), Neil Collinson (4), Laura Ishak (1), Barbara Zrinscak (5), Bruce Belanger (1), Catherine Granier (4), Kai Lin (1), Aeron Hurt (3), Xiao-Jian Zhou (1), Steffen Wildum (3), Janet Hammond (1) - (1) Atea Pharmaceuticals, Inc., United States, (2) Genentech Inc., United States, (3) Hoffmann-La Roche Ltd., Switzerland, (4) Hoffmann-La Roche Ltd., United Kingdom, (5) Hoffmann-La Roche Ltd., Canada 121P2946 Evaluation of SYBR green I-based reverse tran- scription-loop-mediated isothermal amplification (RT-LAMP) for the detection of Asian lineage ZIKV in various clinical samples Atchara Phu- mee 17-04-202312:00 Poster Area PS009 Poster Session 1i. Basic and applied virology (incl. in vitro and in vivo models, novel methods) 12:00 01. Viral infection & di sease (non COVID-19) Padet Siriyasatien (1), Supaporn Wacharapluesadee (2), Atchara Phumee (3, 4) - (1) Center Of Excellence In Vector Biology And Vector Borne Diseases, Department Of Parasitology, Faculty Of Medicine, Chulalongkorn University, Thailand, (2) Thai Red Cross Emerging Infectious Diseases Clinical Centre, King Chulalongkorn Memorial Hospital, Faculty Of Medicine, Chulalongkorn University, Thailand, (3) Department Of Medical Technology, School Of Allied Health Sciences, Walailak University, Thailand, (4) Excellent Center For Dengue And Community Public Health (Ec For Dach), Walailak University, Thailand 122P2761 Social contact patterns in Japan during the CO- VID-19 pandemic during and after the Tokyo Olympic Shinya Tsuzuki17-04-202312:00 Poster Area PS092 Poster Session 12k. Other societal aspects (incl. economics, mental health) 12:0012. COVID-19 Shinya Tsuzuki (1), Yusuke Asai (1), Yoko Ibuka (2), Tomoki Nakaya (3), Norio Ohmagari (1), Niel Hens (4), Philippe Beutels (4) - (1) National Center For Global Health And Medicine, Japan, (2) Keio University, Japan, (3) Tohoku University, Japan, (4) University Of Antwerp, Belgium 123P2989 The association between seasonal influenza vac- cination and antimicrobial consumption in Japan from 2014/15 to 2019/20 season Shinya Tsuzuki17-04-202312:00 Poster Area PS071 Poster Session 10c. General vaccinology (incl. in vitro and in vivo studies, policy, social aspects) 12:00 10. Immunology, Immune compromise & vaccinology Shinya Tsuzuki (1), Fumiko Murata (2), Megumi Maeda (2), Yusuke Asai (1), Ryuji Koizumi (1), Norio Ohmagari (1), Haruhisa Fukuda (2) - (1) National Center For Global Health And Medicine, Japan, (2) Kyushu University, Japan 124P1455 Occurrence of Q-fever fatigue syndrome after acute Q-fever illness in Germany: results from an outbreak investigation in Baden-Wuerttemberg, Germany 2019-2022 Larissa Dangel16-04-202312:00 Poster Area PS016 Poster Session 2g. Zoonotic bacterial infections (incl. foodborne, waterborne and vector-borne pathogens, veteri- nary microbiology and One Health aspects, excl. AMR) 12:00 02. Bacterial infection & disease Larissa Dangel (1, 2), Maylin Meincke (1), Clara Schoneberg (3), Fenja Winter (3), Amely Campe (3), Silke Fischer (1) - (1) State Health Office Baden-Wuerttemberg, Germany, (2) Public Health Microbiology (Euphem), European Centre For Disease Prevention And Control (Ecdc), Sweden, (3) Department Of Biometry, Epidemiology And Information Processing, Who Collaborating Centre For Re-Search And Training For Health In The Human-Animal-Environment Interface, University For Veterinary Medicine Hannover, Germany 128P1922 Development of a case-fatality prognostic score for HIV-associated histoplasmosis Ugo Françoise16-04-202312:00 Poster Area PS042 Poster Session 6a. Fungal disease epidemiology12:00 06. Fungal infection & disease Ugo Françoise (1), Mathieu Nacher (1), Morgane Bourne-Watrin (2), Loïc Epelboin (3), Camille Thorey (3), Jean-Francois Carod (4), Magalie Demar (4), Félix Djossou (3), Pierre Couppié (2), Antoine Adenis (1) - (1) Clinical Investigation Center, Guyane Française, (2) Dermatology, Guyane Française, (3) Infectious Diseases, Guyane Française, (4) Microbiology, Guyane Française 131P2077 The role of bile microbiome in pancreatic and extra pancreatic cancer patients Paola Di Carlo16-04-202312:00 Poster Area PS046 Poster Session 6e. Basic mycology (incl. in vitro and in vivo studies, pathogenesis) 12:00 06. Fungal infection & disease Paola Di Carlo (1), Nicola Serra (2), Francesco D‘Arpa (1), Teresa Maria Assunta Fasciana (1), Silvia Pecoraro (1), Manfredi Piccione (1), Monia Alfonzo (1), Marcello Trizzino (3), Federica Zichichi (1), Cascio Antonio (1), Consolato Maria Sergi (4) - (1) University Of Palermo, Italy, (2) University Of Naples, Italy, (3) Policlinico Universitario Di Palermo, Italy, (4) University Of Ottawa, Canada 133O0342 Can AST/ALT predict mortality in Crimean-Congo haemorrhagic fever? Esma Eryil- maz-Eren 15-04-202316:15Hall NOS072 1-hour Oral Session TAE Research Bites16:1511. Other Esma Eryilmaz-Eren (1), Ayse Turunc-Ozdemir (1), Azade Kanat (1), Zeynep Ture (2), Aysin Kilinc-Toker (1), Ilhami Celik (1) - (1) Kayseri City Education And Research Hospital, Turkey, (2) Erciyes University, Faculty Of Medicine, Turkey 134P1915 Effect of dexamethasone on the incidence and outcome of COVID-19 associated pulmonary aspergillosis (CAPA) in critically ill patients: a single-centre experience Simon Dubler16-04-202312:00 Poster Area PS042 Poster Session 6a. Fungal disease epidemiology12:00 06. Fungal infection & disease Simon Dubler (1), Ömer Can Turan (1), Karsten Schmidt (1), Peter-Michael Rath (2), Hedda-Luise Verhasselt (2), Sandra Maier (3), Annabell Skarabis (1), Thorsten Brenner (1), Frank Herbstreit (1) - (1) Department Of Anesthesiology And Intensive Care Medicine, University Hospital Essen, University Duisburg-Essen, Germany, (2) Institute Of Medical Microbiology, Essen Centre Of Excellence In Clinical And Laboratory Mycology And Clinical Studies, University Hospital Essen, University Duisburg-Essen, Germany, (3) Institute Of Diagnostic And Interventional Radiology And Neuroradiology, University Hospital Essen, University Duisburg-Essen, Germany 135P1881 Rapid identification of intra-amniotic infection using nanopore-based sequencing Pisut Pongchai- kul 16-04-202312:00 Poster Area PS035 Poster Session 4j. Other novel diagnostic tech- nologies 12:00 04. Diagnostic micro biology Pisut Pongchaikul (1), Piya Chaemsaithong (2, 3), Pornpun Vivithanaporn (1), Piroon Jenjaroenpun (4), Thidathip Wongsurawat (4), Iyarit Thaipisuttikul (4) - (1) Chakri Naruebodindra Medical Institute, Faculty Of Medicine Ramathibodi Hospital, Mahidol University, Thailand, (2) Department Of Obstetrics And Gynecology, Faculty Of Medicine Ramathibodi Hospital, Mahidol University, Thailand, (3) Department Of Obstetrics And Gynecology, Wayne State University, United States, (4) Department Of Microbiology, Faculty Of Medicine Siriraj Hospital, Mahidol University, Thailand 137P2759 Practices of community pharmacists towards COVID-19 treatment in Vietnam: a simulated client study Phuong Quan17-04-202312:00 Poster Area PS091 Poster Session 12j. Preparedness and response (COVID and future pandemics) 12:0012. COVID-19 Quoc-Hoa Nguyen, Suong Duong, Phuong Quan, Thanh-Tuyen Du, Uyen Truong, Thi-Quynh-Nga Nguyen, Tuan-Dung Nguyen - (1) Faculty Of Pharmacy, University Of Medicine And Pharmacy At Ho Chi Minh City, Vietnam 138P3248 An outbreak of colistin-resistant, carbapenema- se (blaNDM, blaOXA-232) producing Klebsiella pneumoniae causing bloodstream infection among neonates at a tertiary care hospital in India Chinmoy Sahu18-04-202312:00 Poster Area PS095 Poster Session 13b. Bacterial infections12:00 13. Case reports and case series (n<10) Chinmoy Sahu, Ashutosh Pathak, Nidhi Tejan - (1) Sgpgi, IndiaFINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 2023 15 CategorySub-categoryLink AbstractsLink EposterLink Oral Session 07. Parasitic diseases & global health 7a. Parasitic disease epidemiology https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11252&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P3078 13. Case reports and ase series (n<10) 13d. Parasitic infections https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11255&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P3434 03. Bacterial suscepti- bility & resistance 3d. Resistance mechanisms incl. in vitro and in vivo studies, mobile elements (excl. TB) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11260&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0445 12. COVID-19 12b. Epidemiology - local, regional, national, global https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11261&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2428 Pharmaceutical University, Japan 02. Bacterial infection & disease 2e. Community acquired skin, soft tissue, bone & joint infections (incl. epi- demiology, clinical, imaging, treatment & prevention, excl. prostheses) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11263&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=E0079https://online.eccmid.org/programme-live-1?coday=2023-04-15&openSession=EF015 12. COVID-19 12c. Clinical features, case manage- ment, complications, outcome (incl. long-term) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11264&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2567 12. COVID-19 12e. Drug development and treatment modalities (incl. in vitro, animal, clinical trials, resistance) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11270&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2629 ond (1) - (1) Atea Pharmaceuticals, Inc., United States, (2) Genentech Inc., United States, (3) Hoffmann-La Roche Ltd., Switzerland, (4) Hoffmann-La Roche Ltd., United Kingdom, (5) Hoffmann-La Roche Ltd., Canada 01. Viral infection & di- ease (non COVID-19) 1i. Basic and applied virology (incl in vi- tro and in vivo models, novel methods) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11271&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2946 g Infectious Diseases Clinical Centre, King Chulalongkorn Memorial Hospital, Faculty Of Medicine, Chulalongkorn University, Thailand, (3) Department Of Medical Technology, School Of Allied Health Sciences, Walailak University, Thailand, (4) Excellent Center For 12. COVID-19 12k. Other societal aspects (incl. econo- mics, mental health) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11272&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2761 erp, Belgium 10. Immunology, mmune compromise & vaccinology 10c. General vaccinology (incl. in vitro and in vivo studies, policy, social as- pects) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11273&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2989 02. Bacterial infection & disease 2g. Zoonotic bacterial infections (incl. foodborne, waterborne and vector-bor- ne pathogens, veterinary microbiology and One Health aspects, excl. AMR) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11274&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1455 ntrol (Ecdc), Sweden, (3) Department Of Biometry, Epidemiology And Information Processing, Who Collaborating Centre For Re-Search And Training For Health In The Human-Animal-Environment Interface, University For Veterinary Medicine Hannover, Germany 06. Fungal infection & disease 6a. Fungal disease epidemiology https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11278&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1922 ermatology, Guyane Française, (3) Infectious Diseases, Guyane Française, (4) Microbiology, Guyane Française 06. Fungal infection & disease 6e. Basic mycology (incl. in vitro and in vivo studies, pathogenesis) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11281&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2077 rmo, Italy, (2) University Of Naples, Italy, (3) Policlinico Universitario Di Palermo, Italy, (4) University Of Ottawa, Canada 11. Other https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11283&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-15&openSession=OS072 06. Fungal infection & disease 6a. Fungal disease epidemiology https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11284&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1915 versity Hospital Essen, University Duisburg-Essen, Germany, (2) Institute Of Medical Microbiology, Essen Centre Of Excellence In Clinical And Laboratory Mycology And Clinical Studies, University Hospital Essen, University Duisburg-Essen, Germany, (3) Institute Of 04. Diagnostic micro- biology 4j. Other novel diagnostic technologies https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11285&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1881 Thailand, (2) Department Of Obstetrics And Gynecology, Faculty Of Medicine Ramathibodi Hospital, Mahidol University, Thailand, (3) Department Of Obstetrics And Gynecology, Wayne State University, United States, (4) Department Of Microbiology, Faculty Of 12. COVID-19 12j. Preparedness and response (COVID and future pandemics) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11287&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2759 13. Case reports and ase series (n<10) 13b. Bacterial infections https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11288&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P3248ABSTRACTS16 Abstracts Nr & Co-authors Presentation Nr TitlePresenterDateTime Inter- vention LocationSession Code Session TypeSessionSession Time Category 139E0101 Mortality of cancer patients following hospitali- sation with COVID-19 during the Omicron variant wave: a retrospective matched cohort study Noa Eliakim Raz15-04-202310:06Arena 2EF017 1-hour ePoster Flash Session Critical issues of COVID-19 in immunodeficient patients 9:3012. COVID-19 Noa Eliakim Raz (1), Irit Ayalon-Dangur (1), Amos Stemmer (2), Bar Basharim (3), Noa Bigman-Peer (3), Salomon Stemmer (3) - (1) Department Of Internal Medicine E, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Sackler Faculty Of Medicine, Tel Aviv University, Israel, (2) Department Of Oncology, Sheba Medical Center, Tel Hashomer, Israel, (3) Department Of Internal Medicine E, Rabin Medical Center, Beilinson Hospital, Israel 141P0666 A comparison between blood culture specimen drawn through one and two lumens of a multi-lu- men central venous catheter in the diagnosis of catheter-related bloodstream infection:the first prospective study Sorakai Wong- paiboonwatana 15-04-202312:00 Poster Area PS055 Poster Session 8a. Intravascular catheter-related infections 12:00 08. Healthcare-as sociated infections, infection prevention & control Sorakai Wongpaiboonwatana (1), Gompol Suwanpimolkul (1), Thanitha Chatsuwan (2), Chusana Suankratay (1) - (1) Division Of Infectious Diseases, Department Of Medicine, Faculty Of Medicine, Chulalongkorn University, Thailand, (2) Department Of Microbiology, Faculty Of Medicine, Chulalongkorn University, Thailand 142P1923 Epidemiology of dermatomycoses and onychomy- coses in Ireland (2001 to 2020) : a single-institu- tion review James Powell16-04-202312:00 Poster Area PS042 Poster Session 6a. Fungal disease epidemiology12:00 06. Fungal infection & disease James Powell (1, 2), Emma Porter (2), Sinead Field (2), Nuala O Connell (2, 1), Kieran Carty (2), Colum P Dunne (1) - (1) University Of Limerick, Ireland, (2) University Hospital Limerick, Ireland 145P2615 Baseline serum anti-SARS-CoV-2 antibody testing and clinical outcomes in a phase 3 randomised trial (MOVe-OUT) comparing molnupiravir with placebo for treating COVID-19 Matthew G. Johnson 17-04-202312:00 Poster Area PS086 Poster Session 12e. Drug development and treatment modalities (incl. in vitro, animal, clinical trials, resistance) 12:0012. COVID-19 Julie M. Strizki, Matthew G. Johnson, Ying Zhang, Patricia Carmelitano, Michelle L. Brown, Amanda Paschke, Carisa De Anda, Jay A. Grobler - (1) Merck Sharp & Dohme Llc, United States 146P1996 Dermatology mycology diagnostics in Ireland: a national deficits of international relevance James Powell16-04-202312:00 Poster Area PS043 Poster Session 6b. Diagnostic mycology (incl. traditional, molecular and other methods) 12:00 06. Fungal infection & disease James Powell (1, 2), Emma Porter (2), Siobhan Rafferty (2), Sinead Field (2), Nuala H O Connell (2, 1), Colum P Dunne (1) - (1) University Of Limerick, Ireland, (2) University Hospital Limerick, Ireland 147P3316 The successful of AFB-smear guided therapy in patient with culture negative sporotrichoid lym- phocutaneous infection Monprach Harnphadung- kit 18-04-202312:00 Poster Area PS095 Poster Session 13b. Bacterial infections12:00 13. Case reports and case series (n<10) Jathurong Kittrakulrat, Monprach Harnphadungkit, Gompol Suwanpimolkul - (1) King Chulalongkorn Memorial Hospital, Thailand 151O1300 Kinetics of glucose-6-phosphate dehydrogenase (G6PD) activity during Plasmodium vivax infection Laureen Dahu- ron 18-04-202314:54Hall EOS267 2-hour Oral Session Malaria: challenges in LMICs and HICs 13:30 07. Parasitic diseases & global health Laureen Dahuron (1), Juste Goungounga (2, 3), Moustapha Drame (4), Maylis Douine (5), Mathieu Nacher (5), Theo Blaise (5), Emilie Mosnier (6), Lise Musset (7), Felix Djossou (1), Loic Epelboin (1, 5) - (1) Infectious And Tropical Diseases Department, Guyane Française, (2) Bourgogne University, France, (3) Inserm Umr University Of Health Sciences, Cambodge, (7) Parasitology Laboratory, National Malaria Reference Center, Guyane Française 152P0913 Infection prevention and control measures to protect healthcare workers against COVID-19 in Indonesia: use of personal protective equipment Indri Rooslami- ati Supriadi 15-04-202312:00 Poster Area PS063 Poster Session 8i. Healthcare workers and infec- tion prevention (incl. vaccination, behavioural aspects, training and practices) 12:00 08. Healthcare-as sociated infections, infection prevention & control Indri Rooslamiati Supriadi (1, 2, 3), Cynthia P Haanappel (3), Leli Saptawati (4, 5), Nani H Widodo (6), Gortap Sitohang (7), Yuslely Usman (8), Ida Bagus Anom (6), Ratih Dian Saraswati (1), Hindra Irawan Satari (7), Anne F. Voor In ‘T Holt (3), Juliëtte A. Severin (3) - (1) Center For Health Resilience And Resource Policy, Health Policy Agency, Ministry Of Health Of Indonesia, Indonesia, (2) Department Of Cardiology, University Medical Centre Utrecht, Netherlands, (3) Department Of Medical Microbiology And Infectious Diseases, Erasmus University Medical Centre, Netherlands, (4) Department Of Microbiology, Faculty Of Medicine, Universitas Sebelas Maret, Indonesia, (5) Department Of Microbiology, Moewardi Teaching Hospital, Indonesia, (6) Directorate Of Referral Health Care, Ministry Of Health Of Indonesia, Indonesia, (7) Cipto Mangunkusumo Hospital, Ministry Of Health Of Indonesia, Indonesia, (8) Center For Health Financing And Decentralization Policy, Health Policy Agency, Ministry Of Health Of Indonesia, Indonesia 153P0942 In-host adaptation of Staphylococcus aureus during recurrent prosthetic joint infections: a retrospective longitudinal study Charles Mau- rille 15-04-202312:00 Poster Area PS064 Poster Session 9a. Microbial pathogenesis and virulence 12:00 09. Experimental microbiology, micro bial pathogenesis & biofilm Charles Maurille (1, 2), François Gravey (2, 3), Jean-Christophe Giard (2), Jocelyn Michon (1), Renaud Verdon (1, 2), Simon Le Hello (2, 3), Christophe Isnard (2, 3) - (1) Normandie Univ, Unicaen, Chu De Caen Normandie, Department Of Infectious Diseases, France, (2) Normandie Univ, Unicaen, Unirouen, Inserm Umr 154P2235 Pharmacokinetics and safety of daptomycin admi- nistered subcutaneously in healthy volunteers: a single-blinded randomised cross-over trial Charles Mau- rille 17-04-202312:00 Poster Area PS037 Poster Session 5b. Pharmacokinetics/pharma- codynamics of antibacterial drugs & therapeutic drug monitoring 12:00 05. New antibacte rial agents, PK/PD & Stewardship Charles Maurille (1), Marie-Clémence Verdier (2), Christian Creveuil (3), Jean-Jacques Parienti (3, 4), Jocelyn Michon (1), Laure Peyro-Saint-Paul (3), Sylvie Brucato (3), Sylvie Dargère (1, 4), Aurélie Baldolli (1), Renaud Verdon (1, 4) - (1) Normandie Univ, Unicaen, Chu De Caen Normandie, Department Of Infectious Diseases, France, (2) Univ Rennes, Chu Rennes, Department Of Pharmacology, Inserm, Ehesp, Irset (Institut De Recherche En Santé, Environnement Et Travail) - Umr_S Chu De Caen Normandie, Department Of Biostatistics And Clinical Research, France, (4) Normandie Univ, Unicaen, Unirouen, Inserm Umr 131 1 Dynamicure, France 156P3212 Breast abscess due to Burkholderia pseudomallei mimicking malignancy: an uncommonly encounte- red clinical scenario causing diagnostic dilemma Srujana Mo- hanty 18-04-202312:00 Poster Area PS095 Poster Session 13b. Bacterial infections12:00 13. Case reports and case series (n<10) Srujana Mohanty, Gayatree Nayak, Dilip Kumar Muduly, Hemanth S Ghalige - (1) All India Institute Of Medical Sciences Bhubaneswar, India 158P0478 Impact of phenotypic expression of acquired re- sistance to temocillin in Escherichia coli on efficacy in a murine intra-abdominal infection model Elise Mallart15-04-202312:00 Poster Area PS021 Poster Session 3d. Resistance mechanisms incl. in vitro and in vivo studies, mobile elements (excl. TB) 12:00 03. Bacterial suscepti bility & resistance Elise Mallart (1), François Guérin (2, 3), Ariane Amoura (1), Antoine Hamon (1), Imane El Meouche (1), Sara Dion (1), Françoise Chau (1), Agnès Lefort (1, 4), Bruno Fantin (1), Vincent Cattoir (2, 3), Victoire De Lastours (1, 4) - (1) Inserm, Iame, Umr 113 7, Université Paris Cité, France, (2) Inserm U 159P0894Pneumonia bundle in real life Maria Veronica Paz 15-04-202312:00 Poster Area PS061 Poster Session 8g. Infection control interventions and trials (incl. microbiota trans- plantation) 12:00 08. Healthcare-as sociated infections, infection prevention & control Maria Veronica Paz, Rodrigo Alzola, María Laura D’ Agostino, Franco Garibaldi, Rosa Orellana, Marisa Paniagua, Soledad Samonte, Analía Santillán - (1) Sanatorio De Los Arcos, Argentina 162P1419 Re-thinking septic arthritis diagnosis: a retrospecti- ve cohort study examining synovial fluid leucocyte counts Imal Hemach- andra 16-04-202312:00 Poster Area PS014 Poster Session 2e. Community acquired skin, soft tissue, bone & joint infections (incl. epidemiology, clinical, ima- ging, treatment & prevention, excl. prostheses) 12:00 02. Bacterial infection & disease Imal Hemachandra - (1) John Hunter Hospital, Australia 163P2452 Impact of SARS-CoV-2 infection during pregnancy and neonatal outcome Eduardo Rey- na-Villasmil 17-04-202312:00 Poster Area PS083 Poster Session 12b. Epidemiology - local, regio- nal, national, global 12:00 12. COVID-19 Alison Tyler (1), Nikki Elliot (1), Danica James (2), Bella Rolland (3), Holly Michaels (4), Jorly Mejia-Montilla (5), Eduardo Reyna-Villasmil (5) - (1) Department Of Public Health And Primary Care, United States, (2) Department Of Obstetrics And Gynecology, United States, (3) Center For Women’S Reproductive Health. Lexington Medical Center., United States, (4) Department Of Obstetrics. Lexington Medical Center, United States, (5) Service Of Applied Science. Healthnomics, Spain 164P0312 One Health investigation of CTX-M type exten- ded-spectrum beta-lactamase-producing Escheri- chia coli isolated from food and human Jiang Shuo15-04-202312:00 Poster Area PS019 Poster Session 3b. Resistance surveillance and epidemiology: Gram-negatives 12:00 03. Bacterial suscepti bility & resistance Jiang Shuo, Cao Hui Luo, Fang Han Shu, Tong Mickey, Chan You Xiang, Chow Frankie, Ho Pak Leung - (1) Department Of Microbiology, And Carol Yu Centre For Infection, Queen Mary Hospital, Hong-Kong, ChinaFINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 2023 17 CategorySub-categoryLink AbstractsLink EposterLink Oral Session 12. COVID-19 12c. Clinical features, case manage- ment, complications, outcome (incl. long-term) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11289&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=E0101https://online.eccmid.org/programme-live-1?coday=2023-04-15&openSession=EF017 rsity, Israel, (2) Department Of Oncology, Sheba Medical Center, Tel Hashomer, Israel, (3) Department Of Internal Medicine E, Rabin Medical Center, Beilinson Hospital, Israel 08. Healthcare-as- ociated infections, nfection prevention & ontrol 8a. Intravascular catheter-related infections https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11291&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0666 , Faculty Of Medicine, Chulalongkorn University, Thailand 06. Fungal infection & disease 6a. Fungal disease epidemiology https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11292&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1923 12. COVID-19 12e. Drug development and treatment modalities (incl. in vitro, animal, clinical trials, resistance) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11295&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2615 06. Fungal infection & disease 6b. Diagnostic mycology (incl. traditio- nal, molecular and other methods) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11296&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1996 13. Case reports and ase series (n<10) 13b. Bacterial infections https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11297&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P3316 07. Parasitic diseases & global health 7d. Antiparasitic drugs & treatment (incl. clinical trials) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11302&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-18&openSession=OS267 aise, (2) Bourgogne University, France, (3) Inserm Umr 123 1, Umr 123 1, France, (4) Department Of Clinical Research And Innovation, University Hospital Of Martinique, Martinique, (5) West Indies-French Guiana Clinical Investigation Center, Guyane Française, (6) 08. Healthcare-as- ociated infections, nfection prevention & ontrol 8i. Healthcare workers and infection prevention (incl vaccination, behaviou- ral aspects, training and practices) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11303&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0913 ) Center For Health Resilience And Resource Policy, Health Policy Agency, Ministry Of Health Of Indonesia, Indonesia, (2) Department Of Cardiology, University Medical Centre Utrecht, Netherlands, (3) Department Of Medical Microbiology And Infectious Diseases, Of Health Of Indonesia, Indonesia, (7) Cipto Mangunkusumo Hospital, Ministry Of Health Of Indonesia, Indonesia, (8) Center For Health Financing And Decentralization Policy, Health Policy Agency, Ministry Of Health Of Indonesia, Indonesia 09. Experimental microbiology, micro- bial pathogenesis & biofilm 9a. Microbial pathogenesis & virulence https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11304&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0942 2) Normandie Univ, Unicaen, Unirouen, Inserm Umr 131 1 Dynamicure, France, (3) Normandie Univ, Unicaen, Chu De Caen Normandie, Department Of Microbiology, 140 00 Caen, France, France 05. New antibacte- ial agents, PK/PD & tewardship 5b. Pharmacokinetics/pharmacody- namics of antibacterial drugs & thera- peutic drug monitoring https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11305&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2235 u De Caen Normandie, Department Of Infectious Diseases, France, (2) Univ Rennes, Chu Rennes, Department Of Pharmacology, Inserm, Ehesp, Irset (Institut De Recherche En Santé, Environnement Et Travail) - Umr_S 108 5, France, (3) Normandie Univ, Unicaen, 13. Case reports and ase series (n<10) 13b. Bacterial infections https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11307&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P3212 03. Bacterial suscepti- bility & resistance 3d. Resistance mechanisms incl. in vitro and in vivo studies, mobile elements (excl. TB) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11309&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0478 Paris Cité, France, (2) Inserm U 123 0 Brm, Université De Rennes, France, (3) Service De Bactériologie-Hygiène Hospitalière, Chu Pontchaillou, France, (4) Hôpital Beaujon, Assistance Publique Hôpitaux De Paris, France 08. Healthcare-as- ociated infections, nfection prevention & ontrol 8g. Infection control interventions and trials (incl. microbiota transplantation) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11310&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0894 02. Bacterial infection & disease 2e. Community acquired skin, soft tissue, bone & joint infections (incl. epi- demiology, clinical, imaging, treatment & prevention, excl. prostheses) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11313&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1419 12. COVID-19 12b. Epidemiology - local, regional, national, global https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11314&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2452 tes, (3) Center For Women’S Reproductive Health. Lexington Medical Center., United States, (4) Department Of Obstetrics. Lexington Medical Center, United States, (5) Service Of Applied Science. Healthnomics, Spain 03. Bacterial suscepti- bility & resistance 3b. Resistance surveillance & epidemio- logy: Gram-negatives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11315&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0312ABSTRACTS18 Abstracts Nr & Co-authors Presentation Nr TitlePresenterDateTime Inter- vention LocationSession Code Session TypeSessionSession Time Category 165P2820 Prospective screening of rocahepevirus ratti infec- tion in a patient with acute hepatitis in Spain Antonio Ri- vero-Juarez 17-04-202312:00 Poster Area PS002 Poster Session 1b. Viral hepatitis (incl. diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibili- ty/resistance) 12:00 01. Viral infection & di sease (non COVID-19) Diana Corona-Mata (1), Pedro Lopez-Lopez (1), Ana Belen Perez-Jimenez (2), Carolina Freyre-Carrillo (3), Juan Antonio Pineda (4), Antonio Aguilera (5), Ana Fuentes (6), Juan Carlos Alados (7), Gabriel Reina (8), Encarnacion Ramirez-Arellano (9), Isabel Viciana (10), Javier Caballero-Gomez (1), Antonio Rivero (1), Antonio Rivero-Juarez (1) - (1) Unit Of Infectious Diseases, Hospital Universitario Reina Sofia. Instituto Maimonides De Investigación Biomédica De Córdoba (Imibic) . Universidad De Córdoba (Uco), Spain, (2) Unit Of Microbiology, Hospital Universitario Reina Sofia. Instituto Maimonides De Investigación Biomédica De Córdoba (Imibic) . Universidad De Córdoba (Uco), Spain, (3) Clinical Microbiology Unit, University Hospital Of Puerto Real, Spain, (4) Unit Of Infectious Diseases And Microbiology. Hospital Universitario De Valme, Spain, (5) Microbiology Department, Hospital Clínico Universitario & University Of Santiago De Compostela (Usc) /Idis, Spain, (6) Clinical Microbiology Unit, Hospital Universitario Clínico San Cecilio, Granada, Spain; Instituto De Investigacion Biosanitaria Ibs. Granada, Spain, (7) Clinical Microbiology Unit, Hospital Universitario De Jerez, Spain, (8) Microbiology Department, Clínica Universidad De Navarra. Istun, Institute Of Tropical Health, Universidad De Navarra. Idisna, Navarra Institute For Health Research, Spain, (9) Infectious Diseases, Microbiology And Preventive Medicine Unit, Virgen Macarena Univ. Hospital, And Department Of Medicine, University Of Sevilla/Biomedicine Institute Of Sevilla, Spain, (10) Microbiology Department, Hospital Universitario Virgen De La Victoria, Spain 168P0190 Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from patients hospitalised with pneumonia in Europe and the United States: results from the SENTRY Program- me (2019–2021) Helio S. Sader15-04-202312:00 Poster Area PS019 Poster Session 3b. Resistance surveillance and epidemiology: Gram-negatives 12:00 03. Bacterial suscepti bility & resistance Helio S. Sader, Cecilia Carvalhaes, Leonard Duncan, Michael Huband, Dee Shortridge, Andrew Fuhrmeister, Rodrigo Mendes, Mariana Castanheira - (1) Jmi Laboratories, United States 170O1293 Side effects and factors influencing non-adherence to mass drug administration for malaria control in the context of a cluster randomised clinical trial (MATAMAL) on the Bijagós Archipelago, Guinea-Bissau Maeve Barlow18-04-202313:30Hall EOS267 2-hour Oral Session Malaria: challenges in LMICs and HICs 13:30 07. Parasitic diseases & global health Maeve Barlow (1), Harry Hutchins (1), Claire Collin (1), Eunice Teixeira E Silva (2), Beatriz Sanchez (1), Hamadou Boiro (3), Amabelia Rodrigues (4), Anna Last (1) - (1) Clinical Research Department, Faculty Of Infectious And Tropical Diseases, London School Of Hygiene And Tropical Medicine, United Kingdom, (2) Ministry Of Public Health, Guinée-Bissau, (3) Institute Of Studies And Research, Guinée-Bissau, (4) Director Of Research, Bandim Health Project, Guinée-Bissau 172P1356 Mycoplasma penetrans, a possible urogenital bystander more frequent in HIV-positive men and men who have sex with men Sabine Pereyre16-04-202312:00 Poster Area PS013 Poster Session 2d. Community-acquired abdo- minal/gastrointestinal, urinary tract & genital infections (incl. epidemiology, clinical, imaging, treatment & prevention) 12:00 02. Bacterial infection & disease Marie Gardette (1), Arabella Touati (1), Cécile Laurier-Nadalié (1), Cécile Bébéar (1, 2), Sabine Pereyre (1, 2) - (1) Bordeaux University Hospital, National Reference Centre For Bacterial Sexually Transmitted Infections, France, (2) Univ. Bordeaux, Cnrs, Umr 523 4, France 173O0876 Severe toxoplasmosis pneumonia requiring in- tubation in an immunocompetent patient after consumption of deer meat in the southern United States David Ruten- berg 17-04-202311:33Hall POS179 1-hour Case Session Puzzling parasites11:00 13. Case reports and case series (n<10) David Rutenberg (1), Yumeng Zhang (1), Jose Montoya (2), Despina Contopoulos-Ioannidis (3), Amro Elshereye (1), John Sinnott (1), Kami Kim (1), Milani Ava (1), Carolina Strosberg (4) - (1) University Of South Florida, United States, (2) Sutter Health, United States, (3) Stanford University, United States, (4) Tampa General Hospital, United States 179P2783 Evaluating the test accuracy of an HIV-1/2 rapid test used with a 0.01M phosphate buffer saline produced at the MRC the Gambia Anna Boté Casamitjana 17-04-202312:00 Poster Area PS001 Poster Session 1a. HIV/AIDS (incl. diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance) 12:00 01. Viral infection & di sease (non COVID-19) Anna Boté Casamitjana (1, 2), Tisbeh Faye-Joof (2), Ousman Bah (2), Sira Jallow (2), Alagie Camara (2), Olimatou Jallow (2), Karen Forrest (2), Behzad Nadjm (1, 2) - (1) London School Of Hygiene And Tropical Medicine, United Kingdom, (2) Mrc Unit The Gambia At Lshtm, Gambia 180P1673 Clarifying uncertainty in sepsis diagnosis using a gene expression assay Peter Meijer16-04-202312:00 Poster Area PS029 Poster Session 4d. Molecular diagnostics (incl. POCT and syndromic testing) 12:00 04. Diagnostic micro biology Erkan Hassan (1), Peter Meijer (2), Roy Davis (3), Silvia Cermelli (3), Robert Balk (4, 5) - (1) Consultant Immunexpress Inc., United States, (2) Immunexpress Inc., Netherlands, (3) Immunexpress Inc., United States, (4) Rush Medical College And Rush University Medical Center, United States, (5) On Behalf Of Neptune And Venus Collaborators , 182P2072 Review of guideline observance in relation to infectious diseases consultation for adult patients with candidemia living in Calgary Alberta, Canada (2010 – 2018) Samuel Bouras- sa-Blanchette 16-04-202312:00 Poster Area PS045 Poster Session 6d. Antifungal drugs & treatment (incl. clinical trials) 12:00 06. Fungal infection & disease Samuel Bourassa-Blanchette (1), Marit Biesheuvel (2), John Lam (2), Alexander Kipp (2), Deirdre Church (2), Bruce Dalton (3), Herman Barkema (2), Daniel Gregson (2) - (1) Memorial University, Canada, (2) University Of Calgary, Canada, (3) Alberta Health Services, Canada 186P0670 Neutropaenia at the time of central venous cathe- ter (CVC) insertion is not a risk factor for CVC-rela- ted bloodstream infections (CRBSI) Enrico Schalk15-04-202312:00 Poster Area PS055 Poster Session 8a. Intravascular catheter-related infections 12:00 08. Healthcare-as sociated infections, infection prevention & control Enrico Schalk (1), Timo Schmitt (2, 3), Jens Panse (4, 5), Eva Fiegle (4, 5), Jan-Hendrik Naendrup (6, 5), Boris Böll (6, 5), Marcus Hentrich (7), Daniel Teschner (2, 8), Martin Schmidt-Hieber (9) - (1) Otto-Von-Guericke University Magdeburg, Medical Center, Department Of Hematology And Oncology, Germany, (2) University Medical Center Of The Johannes Gutenberg University Mainz, Department Of Hematology, Medical Oncology, And Pneumology, Germany, (3) Hamm Hospital Nahetal, Germany, (4) University Hospital Rwth Aachen, Medical Faculty, Department Of Oncology, Hematology, Hemostaseology And Stem Cell Transplantation, Germany, (5) Center For Integrated Oncology (Cio), Aachen, Bonn, Cologne, Düsseldorf (Abcd), Germany, (6) University Hospital Of Cologne, Department Of Internal Medicine I, Germany, (7) Red Cross Hospital Munich, Department Of Hematology And Oncology, Germany, (8) University Hospital Würzburg, Department Of Internal Medicine Ii, Germany, (9) Carl-Thiem Hospital Cottbus, Clinic Of Hematology, Oncolo gy, Pneumology And Nephrology, Germany 187P1525 Barriers and enablers to blood culture sampling: a systematic review and theoretical domains frame- work survey in Indonesia, Thailand and Vietnam Direk Limmat- hurotsakul 16-04-202312:00 Poster Area PS026 Poster Session 4a. Diagnostic bacteriology (incl. culture based, traditional and general microbiology, serology) 12:00 04. Diagnostic micro biology Pornpan Suntornsut (1), Koe Stella Asadina (2), Ralalicia Limato (2), Alice Tamara (2), Linda W.A. Rotty (2), Rendra Bramanti (3), Dwi U. Nusantara (4), Erni J. Nelwan (5), Suwimon Khusuwan (6), Watthanapong Suphamongkholchaikul (7), Parinya Chamnan (7), Watcharapong Piyaphanee (8), Vu Thi Lan Huong (9), Nguyen Hai Yen (9), Khanh Nguyen Hong (9), Pham Ngoc Thach (10), Le Minh Quang (11), Vu Hai Vinh (11), Chau Minh Duc (12), Thi Hoang Dung Em Vo (12), Elinor Harriss (13), H Rogier Van Doorn (9), Raph L Hamers (2), Fabiana Lorencatto (14), Lou Atkins (14), Direk Limmathurotsakul (1, 15, 16) - (1) Mahidol-Oxford Tropical Medicine Research Unit, Faculty Of Tropical Medicine, Mahidol University, Thailand, (2) Oxford University Clinical Research Unit Indonesia, Faculty Of Medicine Universitas Indonesia, Indonesia, (3) Prof. Dr. R.D. Kandou Central Hospital, Indonesia, (4) Pasar Minggu District Hospital, Indonesia, (5) Faculty Of Medicine, Universitas Indonesia, Indonesia, (6) Chiangrai Prachanukroh Hospital, Thailand, (7) Sunpasitthipra song Hospital, Thailand, (8) Faculty Of Tropical Medicine, Mahidol University, Thailand, (9) Oxford University Clinical Research Unit, Vietnam, (10) National Hospital For Tropical Diseases, Vietnam, (11) Viet Tiep Hospital, Vietnam, (12) Dong Thap, Vietnam, (13) Bodleian Health Care Libraries, United Kingdom, (14) Centre For Behaviour Change, University College London, United Kingdom, (15) Centre For Tropical Medicine And Global Health, Nuffield Department Of Medicine, University Of Oxford, United Kingdom, (16) Depart ment Of Tropical Hygiene, Faculty Of Tropical Medicine, Mahidol University, , Thailand 188O0568 ABRomics: an open access online platform on an- timicrobial resistance to store, integrate, analyse and share multi-omics data Etienne Ruppé16-04-202314:06Hall LOS117 1-hour Oral Session Using omics approaches to study AMR 13:30 03. Bacterial suscepti bility & resistance Pierre Marin (1, 2), Julie Lao (1, 3), Romain Dallet (1, 4), Kenzo-Hugo Hillion (5), Aurélien Birer (6), Nadia Goué (2), Richard Bonnet (6), Etienne Ruppé (3), Fabien Mareuil (7), Gildas Le Corguillé (1, 4), Philippe Glaser (8), Claudine Médigue (1, 9) - (1) Cnrs, Institut Français De Bioinformatique, Ifb-Core, Uar Biologique, France, (5) Faculté Des Sciences Techniques, Université De Nantes, F- 440 00, France, (6) Chru Clermont-Ferrand Gabriel-Montpied, France, (7) Institut Pasteur, Université Paris Cité, Bioinformatics And Biostatistics Hub, F- 750 15, France, (8) Institut Pasteur, Unité Eera, Cnrs Umr 189P2822 Meta-analysis: a diagnostic performance of HCV core antigen assay in HIV-infected people Daniel Sepúl- veda-Crespo 17-04-202312:00 Poster Area PS002 Poster Session 1b. Viral hepatitis (incl. diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibili- ty/resistance) 12:00 01. Viral infection & di sease (non COVID-19) Daniel Sepúlveda-Crespo (1, 2), Ana Treviño-Nakoura (3, 4), José M Bellón (5), Óscar Brochado-Kith (1, 2), Ana Virseda-Berdices (1, 2), María A Jiménez-Sousa (1, 2), Pablo Ryan (6, 2), Isidoro Martínez (1, 2), Amanda Fernández-Rodríguez (1, 2), Salvador Resino (1, 2) - (1) Unidad De Infección Viral E Inmunidad. Centro Nacional De Microbiología - Instituto De Salud Carlos Iii, Spain, (2) Centro De Investigación Biomédica En Red En Enfermedades Infecciosas (Ciberinfec), Instituto De Salud Carlos Iii, Spain, (3) Servicio De Medicina Preventiva Y Salud Pública, Hospital Universitario Nuestra Señora De La Candelaria, Spain, (4) Universidad Nacional De Educación A Distancia (Uned), Spain, (5) Instituto De Investigación Sanitaria Gregorio Marañón (Iisgm), Spain, (6) Servicio De Medicina Interna, Hospital Universitario Infanta Leonor, Spain 190P1267 Clinical outcomes after surgical treatment of septic arthritis: a rapid evidence review Iman Islam16-04-202312:00 Poster Area PS011 Poster Session 2b. Severe sepsis, bacteraemia & endocarditis (incl. epidemiology, diagnosis, host bio-markers, treat- ment and outcome prediction) 12:00 02. Bacterial infection & disease Iman Islam (1), Gavin Barlow (1, 2, 3), Gavin Barlow (1, 2, 3) - (1) Hull York Medical School, United Kingdom, (2) The Centre For Immunology And Infection, University Of York, United Kingdom, (3) Hull University Teaching Hospitals Nhs Trust, United Kingdom 192P1015 Endovascular aortic aneurysm repair prosthesis infections: anin vitro model of biofilm formation Torgny Sunner- hagen 15-04-202312:00 Poster Area PS066 Poster Session 9c. Preclinical biofilm studies12:00 09. Experimental microbiology, micro bial pathogenesis & biofilm Torgny Sunnerhagen (1, 2, 3), Franziska Schwartz (3), Lars Christophersen (3), Thomas Bjarnsholt (3, 4), Klaus Qvortrup (5), Nikolaj Eldrup (6), Katja Vogt (6), Claus Moser (3, 7) - (1), Section For Infection Medicinelund University, Sweden, (2) Clinical Microbiology, Hospital Hygiene And Disease Control, Region Skåne, Sweden, (3) Department Of Clinical Microbiology, Rigshospitalet Copenhagen University Hospital, Denmark, (4) Department Of Immunology And Microbiology, Costerton Biofilm Center, University Of Copenhagen, Denmark, (5) Department Of Biomedical Sciences, University Of Copenhagen, Denmark, (6) Department Of Vascular Surgery, Rigshospitalet Copenhagen University Hospital, Denmark, (7) Department Of Immunology And Microbiology, Costerton Biofilm Center, University Of Copenhagen 196P2011 Clinical characteristics and correlation between epidemiological cut-off values (ECV) and mortality in patients withcryptococcosis Eloy Ordaya16-04-202312:00 Poster Area PS044 Poster Session 6c. Antifungal susceptibility testing & resistance (incl. surveillance) 12:00 06. Fungal infection & disease Eloy Ordaya, Omar Abu Saleh, Paschalis Vergidis, Jane Hata, Erin Graf, Nancy Wengenack, Madiha Fida - (1) Mayo Clinic, United StatesFINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 2023 19 CategorySub-categoryLink AbstractsLink EposterLink Oral Session 01. Viral infection & di- ease (non COVID-19) 1b. Viral hepatitis (incl. diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11316&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2820 avier Caballero-Gomez (1), Antonio Rivero (1), Antonio Rivero-Juarez (1) - (1) Unit Of Infectious Diseases, Hospital Universitario Reina Sofia. Instituto Maimonides De Investigación Biomédica De Córdoba (Imibic) . Universidad De Córdoba (Uco), Spain, (2) Unit Of d Microbiology. Hospital Universitario De Valme, Spain, (5) Microbiology Department, Hospital Clínico Universitario & University Of Santiago De Compostela (Usc) /Idis, Spain, (6) Clinical Microbiology Unit, Hospital Universitario Clínico San Cecilio, Granada, Spain; Institute For Health Research, Spain, (9) Infectious Diseases, Microbiology And Preventive Medicine Unit, Virgen Macarena Univ. Hospital, And Department Of Medicine, University Of Sevilla/Biomedicine Institute Of Sevilla, Spain, (10) Microbiology Department, 03. Bacterial suscepti- bility & resistance 3b. Resistance surveillance & epidemio- logy: Gram-negatives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11319&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0190 07. Parasitic diseases & global health 7h. Infections in low-resource settings (incl. epidemiology, burden, health infrastructure, health disparities and vulnerable populations) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11321&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-18&openSession=OS267 ne And Tropical Medicine, United Kingdom, (2) Ministry Of Public Health, Guinée-Bissau, (3) Institute Of Studies And Research, Guinée-Bissau, (4) Director Of Research, Bandim Health Project, Guinée-Bissau 02. Bacterial infection & disease 2d. Community-acquired abdominal/ gastrointestinal, urinary tract & genital infections (incl. epidemiology, clinical, imaging, treatment & prevention) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11323&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1356 nce 13. Case reports and ase series (n<10) 13d. Parasitic infections https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11324&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-17&openSession=OS179 3) Stanford University, United States, (4) Tampa General Hospital, United States 01. Viral infection & di- ease (non COVID-19) 1a. HIV/AIDS (incl. diagnostics & epide- miology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11331&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2783 shtm, Gambia 04. Diagnostic micro- biology 4d. Molecular diagnostics (incl. POCT and syndromic testing) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11332&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1673 al Center, United States, (5) On Behalf Of Neptune And Venus Collaborators , 06. Fungal infection & disease 6d. Antifungal drugs & treatment (incl. clinical trials) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11334&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2072 Canada 08. Healthcare-as- ociated infections, nfection prevention & ontrol 8a. Intravascular catheter-related infections https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11338&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0670 nt Of Hematology And Oncology, Germany, (2) University Medical Center Of The Johannes Gutenberg University Mainz, Department Of Hematology, Medical Oncology, And Pneumology, Germany, (3) Hamm Hospital Nahetal, Germany, (4) University Hospital Rwth nt Of Internal Medicine I, Germany, (7) Red Cross Hospital Munich, Department Of Hematology And Oncology, Germany, (8) University Hospital Würzburg, Department Of Internal Medicine Ii, Germany, (9) Carl-Thiem Hospital Cottbus, Clinic Of Hematology, Oncolo- 04. Diagnostic micro - biology 4a. Diagnostic bacteriology (incl. culture based, traditional and general microbio- logy, serology) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11339&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1525 arapong Piyaphanee (8), Vu Thi Lan Huong (9), Nguyen Hai Yen (9), Khanh Nguyen Hong (9), Pham Ngoc Thach (10), Le Minh Quang (11), Vu Hai Vinh (11), Chau Minh Duc (12), Thi Hoang Dung Em Vo (12), Elinor Harriss (13), H Rogier Van Doorn (9), Raph L Hamers dicine Universitas Indonesia, Indonesia, (3) Prof. Dr. R.D. Kandou Central Hospital, Indonesia, (4) Pasar Minggu District Hospital, Indonesia, (5) Faculty Of Medicine, Universitas Indonesia, Indonesia, (6) Chiangrai Prachanukroh Hospital, Thailand, (7) Sunpasitthipra- eian Health Care Libraries, United Kingdom, (14) Centre For Behaviour Change, University College London, United Kingdom, (15) Centre For Tropical Medicine And Global Health, Nuffield Department Of Medicine, University Of Oxford, United Kingdom, (16) Depart- 03. Bacterial suscepti- bility & resistance 3b. Resistance surveillance & epidemio- logy: Gram-negatives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11340&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-16&openSession=OS117 nçais De Bioinformatique, Ifb-Core, Uar 360 1, France, (2) Aubi Platform, Mésocentre, Université Clermont-Auvergne, France, (3) Université Paris Cité And Université Sorbonne Paris Nord, Inserm, Iame, France, (4) Sorbonne Université, Cnrs, Fr 242 4, Abims, Station eur, Unité Eera, Cnrs Umr 604 , F- 750 15, France, (9) Cnrs Umr 803 0, Université Evry-Val-D‘Essonne, Cea, Genoscope, Labgem, France 01. Viral infection & di- ease (non COVID-19) 1b. Viral hepatitis (incl. diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11341&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2822 - (1) Unidad De Infección Viral E Inmunidad. Centro Nacional De Microbiología - Instituto De Salud Carlos Iii, Spain, (2) Centro De Investigación Biomédica En Red En Enfermedades Infecciosas (Ciberinfec), Instituto De Salud Carlos Iii, Spain, (3) Servicio De Medicina ospital Universitario Infanta Leonor, Spain 02. Bacterial infection & disease 2b. Severe sepsis, bacteraemia & endocarditis (incl. epidemiology, diag- nosis, host bio-markers, treatment and outcome prediction) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11342&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1267 09. Experimental microbiology, micro- bial pathogenesis & biofilm 9c. Preclinical biofilm studies https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11344&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1015 spital Hygiene And Disease Control, Region Skåne, Sweden, (3) Department Of Clinical Microbiology, Rigshospitalet Copenhagen University Hospital, Denmark, (4) Department Of Immunology And Microbiology, Costerton Biofilm Center, University Of Copenhagen, versity Of Copenhagen 06. Fungal infection & disease 6c. Antifungal susceptibility testing & resistance (incl. surveillance) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=11348&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2011Next >